List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Cell-free Tumor DNA Detection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell-free Tumor DNA Detection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell-free Tumor DNA Detection Overall Market Size
2.1 Global Cell-free Tumor DNA Detection Market Size: 2022 VS 2029
2.2 Global Cell-free Tumor DNA Detection Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell-free Tumor DNA Detection Players in Global Market
3.2 Top Global Cell-free Tumor DNA Detection Companies Ranked by Revenue
3.3 Global Cell-free Tumor DNA Detection Revenue by Companies
3.4 Top 3 and Top 5 Cell-free Tumor DNA Detection Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell-free Tumor DNA Detection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell-free Tumor DNA Detection Players in Global Market
3.6.1 List of Global Tier 1 Cell-free Tumor DNA Detection Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell-free Tumor DNA Detection Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell-free Tumor DNA Detection Market Size Markets, 2022 & 2029
4.1.2 Droplet Digital Polymerase Chain Reaction
4.1.3 Tagged-Amplicon Deep Sequencing
4.1.4 Others
4.2 By Type - Global Cell-free Tumor DNA Detection Revenue & Forecasts
4.2.1 By Type - Global Cell-free Tumor DNA Detection Revenue, 2018-2023
4.2.2 By Type - Global Cell-free Tumor DNA Detection Revenue, 2024-2029
4.2.3 By Type - Global Cell-free Tumor DNA Detection Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell-free Tumor DNA Detection Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Stomach Cancer
5.1.4 Liver Cancer
5.1.5 Other
5.2 By Application - Global Cell-free Tumor DNA Detection Revenue & Forecasts
5.2.1 By Application - Global Cell-free Tumor DNA Detection Revenue, 2018-2023
5.2.2 By Application - Global Cell-free Tumor DNA Detection Revenue, 2024-2029
5.2.3 By Application - Global Cell-free Tumor DNA Detection Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cell-free Tumor DNA Detection Market Size, 2022 & 2029
6.2 By Region - Global Cell-free Tumor DNA Detection Revenue & Forecasts
6.2.1 By Region - Global Cell-free Tumor DNA Detection Revenue, 2018-2023
6.2.2 By Region - Global Cell-free Tumor DNA Detection Revenue, 2024-2029
6.2.3 By Region - Global Cell-free Tumor DNA Detection Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cell-free Tumor DNA Detection Revenue, 2018-2029
6.3.2 US Cell-free Tumor DNA Detection Market Size, 2018-2029
6.3.3 Canada Cell-free Tumor DNA Detection Market Size, 2018-2029
6.3.4 Mexico Cell-free Tumor DNA Detection Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cell-free Tumor DNA Detection Revenue, 2018-2029
6.4.2 Germany Cell-free Tumor DNA Detection Market Size, 2018-2029
6.4.3 France Cell-free Tumor DNA Detection Market Size, 2018-2029
6.4.4 U.K. Cell-free Tumor DNA Detection Market Size, 2018-2029
6.4.5 Italy Cell-free Tumor DNA Detection Market Size, 2018-2029
6.4.6 Russia Cell-free Tumor DNA Detection Market Size, 2018-2029
6.4.7 Nordic Countries Cell-free Tumor DNA Detection Market Size, 2018-2029
6.4.8 Benelux Cell-free Tumor DNA Detection Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cell-free Tumor DNA Detection Revenue, 2018-2029
6.5.2 China Cell-free Tumor DNA Detection Market Size, 2018-2029
6.5.3 Japan Cell-free Tumor DNA Detection Market Size, 2018-2029
6.5.4 South Korea Cell-free Tumor DNA Detection Market Size, 2018-2029
6.5.5 Southeast Asia Cell-free Tumor DNA Detection Market Size, 2018-2029
6.5.6 India Cell-free Tumor DNA Detection Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cell-free Tumor DNA Detection Revenue, 2018-2029
6.6.2 Brazil Cell-free Tumor DNA Detection Market Size, 2018-2029
6.6.3 Argentina Cell-free Tumor DNA Detection Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell-free Tumor DNA Detection Revenue, 2018-2029
6.7.2 Turkey Cell-free Tumor DNA Detection Market Size, 2018-2029
6.7.3 Israel Cell-free Tumor DNA Detection Market Size, 2018-2029
6.7.4 Saudi Arabia Cell-free Tumor DNA Detection Market Size, 2018-2029
6.7.5 UAE Cell-free Tumor DNA Detection Market Size, 2018-2029
7 Cell-free Tumor DNA Detection Companies Profiles
7.1 Biocept Inc.
7.1.1 Biocept Inc. Company Summary
7.1.2 Biocept Inc. Business Overview
7.1.3 Biocept Inc. Cell-free Tumor DNA Detection Major Product Offerings
7.1.4 Biocept Inc. Cell-free Tumor DNA Detection Revenue in Global Market (2018-2023)
7.1.5 Biocept Inc. Key News & Latest Developments
7.2 Bio-Rad Laboratories Inc.
7.2.1 Bio-Rad Laboratories Inc. Company Summary
7.2.2 Bio-Rad Laboratories Inc. Business Overview
7.2.3 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Major Product Offerings
7.2.4 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Revenue in Global Market (2018-2023)
7.2.5 Bio-Rad Laboratories Inc. Key News & Latest Developments
7.3 Fluxion Biosciences Inc.
7.3.1 Fluxion Biosciences Inc. Company Summary
7.3.2 Fluxion Biosciences Inc. Business Overview
7.3.3 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Major Product Offerings
7.3.4 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Revenue in Global Market (2018-2023)
7.3.5 Fluxion Biosciences Inc. Key News & Latest Developments
7.4 F. Hoffmann-La Roche AG
7.4.1 F. Hoffmann-La Roche AG Company Summary
7.4.2 F. Hoffmann-La Roche AG Business Overview
7.4.3 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Major Product Offerings
7.4.4 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Revenue in Global Market (2018-2023)
7.4.5 F. Hoffmann-La Roche AG Key News & Latest Developments
7.5 Sysmex Europe SE
7.5.1 Sysmex Europe SE Company Summary
7.5.2 Sysmex Europe SE Business Overview
7.5.3 Sysmex Europe SE Cell-free Tumor DNA Detection Major Product Offerings
7.5.4 Sysmex Europe SE Cell-free Tumor DNA Detection Revenue in Global Market (2018-2023)
7.5.5 Sysmex Europe SE Key News & Latest Developments
7.6 Qiagen
7.6.1 Qiagen Company Summary
7.6.2 Qiagen Business Overview
7.6.3 Qiagen Cell-free Tumor DNA Detection Major Product Offerings
7.6.4 Qiagen Cell-free Tumor DNA Detection Revenue in Global Market (2018-2023)
7.6.5 Qiagen Key News & Latest Developments
7.7 NeoGenomics Laboratories Inc.
7.7.1 NeoGenomics Laboratories Inc. Company Summary
7.7.2 NeoGenomics Laboratories Inc. Business Overview
7.7.3 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Major Product Offerings
7.7.4 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Revenue in Global Market (2018-2023)
7.7.5 NeoGenomics Laboratories Inc. Key News & Latest Developments
7.8 Menarini Silicon Biosystems
7.8.1 Menarini Silicon Biosystems Company Summary
7.8.2 Menarini Silicon Biosystems Business Overview
7.8.3 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Major Product Offerings
7.8.4 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Revenue in Global Market (2018-2023)
7.8.5 Menarini Silicon Biosystems Key News & Latest Developments
7.9 Illumina Inc.
7.9.1 Illumina Inc. Company Summary
7.9.2 Illumina Inc. Business Overview
7.9.3 Illumina Inc. Cell-free Tumor DNA Detection Major Product Offerings
7.9.4 Illumina Inc. Cell-free Tumor DNA Detection Revenue in Global Market (2018-2023)
7.9.5 Illumina Inc. Key News & Latest Developments
7.10 Guardant Health Inc.
7.10.1 Guardant Health Inc. Company Summary
7.10.2 Guardant Health Inc. Business Overview
7.10.3 Guardant Health Inc. Cell-free Tumor DNA Detection Major Product Offerings
7.10.4 Guardant Health Inc. Cell-free Tumor DNA Detection Revenue in Global Market (2018-2023)
7.10.5 Guardant Health Inc. Key News & Latest Developments
7.11 Shanghai Biotecan Medical Diagnostics Co.,Ltd.
7.11.1 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Company Summary
7.11.2 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Business Overview
7.11.3 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Major Product Offerings
7.11.4 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Revenue in Global Market (2018-2023)
7.11.5 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
